妊娠期糖尿病筛查治疗对孕产妇及新生儿影响的应用研究

Application of Gestational Diabetes Screening Treatment of Maternal and Newborn Influence

目的通过临床实践应用研究妊娠期糖尿病筛查治疗对孕产妇及新生儿的影响。方法统计该院于2014年5月—2015年7月收治的于产前检查确诊为妊娠期糖尿病孕妇共计97例作为研究对象,将其中69例确诊为早期妊娠期糖尿病。孕妇列入早期组其余28例中晚期妊娠期糖尿病孕妇列为晚期组。另选同时间与本院收治的正常血糖孕妇90例列为正常组。记录并统计3组孕妇的分娩方式、妊娠期并发症概率以及围生儿并发症概率。结果 1晚期组与早期组、正常组之间的剖宫产率差异有统计学意义(P<0.05),早期组与正常组之间差异无统计学意义(P>0.05);2孕产妇的妊娠期高血压并发症、羊水量、胎膜破损程度与早产指标对比显示,晚期组与早期组、正常组之间差异有统计学意义(P<0.05),早期组与正常组之间差异无统计学意义(P>0.05);3对新生儿的影响对比新生儿的体态,以及有无窘迫、和胆红素血症、血糖指标,晚期组与早期组、正常组之间差异有统计学意义(P<0.05),早期组与正常组之间差异无统计学意义(P>0.05)。结论妊娠期糖尿病筛查治疗对孕产妇及新生儿的健康均具有积极的影响,因此应当及早筛查及早治疗。

Objective Applied research through clinical practice impact on maternal and newborn screening for gestational diabetes treatment. Methods Tatistical hospital in May 2014 to July 2015 were treated in prenatal diagnosis of gestational diabetes, a total of 97 cases of pregnant women as research subjects, which will be 69 cases diagnosed as gestational dia- betes early. Pregnant women included in the early group, and the remaining 28 cases in pregnant women with gestational di- abetes late as the late group. Alternatively the same time with our hospital 90 cases of pregnant women as a normal blood sugar normal. Records and statistics mode of delivery of three groups of pregnant women, the probability of pregnancy com- plications and perinatal complication probability child. Results ① early group and late group, the presence of cesarean sec- tion rate significant difference between the normal group （P 〈0.05）, no statistically significant difference （P between the ear- ly group and the normal group 〉 0.05）. Complication, amniotic fluid, fetal membranes extent of damage in preterm index contrast;② maternal gestational hypertension and showed early group and late group, there are significant differences between the control group （P 〈0.05）, the early group and the normal group no significant difference between （P〉 0.05）. Body influence on neonatal contrast;③ newborn, and whether distress, and hyperbilirubinemia, blood sugar, late group with early group, there was significant difference （P 〈0.05） between the normal group, the early group no significant difference （P〉 0.05） between the normal group. Conclusion Gestational diabetes screening treatment on maternal and newborn health have a positive im- pact, and should therefore be an early screening and early treatment.